EMPIRE-CF: A phase II randomized placebo-controlled trial of once-daily, oral acebilustat in adult patients with cystic fibrosis - Study design and patient demographics.
Saved in:
| Title: | EMPIRE-CF: A phase II randomized placebo-controlled trial of once-daily, oral acebilustat in adult patients with cystic fibrosis - Study design and patient demographics. |
|---|---|
| Authors: | Elborn JS; National Heart and Lung Institute, Imperial College and Royal Brompton Hospital, London, UK. Electronic address: j.elborn@imperial.ac.uk., Ahuja S; Celtaxsys, Inc., 201 17th St NW #530, Atlanta, GA, USA. Electronic address: sahuja@celtaxsys.com., Springman E; Celtaxsys, Inc., 201 17th St NW #530, Atlanta, GA, USA. Electronic address: espringman@celtaxsys.com., Mershon J; Celtaxsys, Inc., 201 17th St NW #530, Atlanta, GA, USA. Electronic address: jmershon@celtaxsys.com., Grosswald R; Celtaxsys, Inc., 201 17th St NW #530, Atlanta, GA, USA. Electronic address: rgrosswald@celtaxsys.com., Rowe SM; Departments of Medicine, Pediatrics, Cell Developmental, and Integrative Biology, University of Alabama at Birmingham, Birmingham, AL, USA; Cystic Fibrosis Research Center, University of Alabama at Birmingham, Birmingham, AL, USA. Electronic address: smrowe@uab.edu. |
| Source: | Contemporary clinical trials [Contemp Clin Trials] 2018 Sep; Vol. 72, pp. 86-94. Date of Electronic Publication: 2018 Jul 26. |
| Publication Type: | Clinical Trial Protocol; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 101242342 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1559-2030 (Electronic) Linking ISSN: 15517144 NLM ISO Abbreviation: Contemp Clin Trials Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 30056216 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: EMPIRE-CF: A phase II randomized placebo-controlled trial of once-daily, oral acebilustat in adult patients with cystic fibrosis - Study design and patient demographics. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Elborn+JS%22">Elborn JS</searchLink>; National Heart and Lung Institute, Imperial College and Royal Brompton Hospital, London, UK. Electronic address: j.elborn@imperial.ac.uk.<br /><searchLink fieldCode="AU" term="%22Ahuja+S%22">Ahuja S</searchLink>; Celtaxsys, Inc., 201 17th St NW #530, Atlanta, GA, USA. Electronic address: sahuja@celtaxsys.com.<br /><searchLink fieldCode="AU" term="%22Springman+E%22">Springman E</searchLink>; Celtaxsys, Inc., 201 17th St NW #530, Atlanta, GA, USA. Electronic address: espringman@celtaxsys.com.<br /><searchLink fieldCode="AU" term="%22Mershon+J%22">Mershon J</searchLink>; Celtaxsys, Inc., 201 17th St NW #530, Atlanta, GA, USA. Electronic address: jmershon@celtaxsys.com.<br /><searchLink fieldCode="AU" term="%22Grosswald+R%22">Grosswald R</searchLink>; Celtaxsys, Inc., 201 17th St NW #530, Atlanta, GA, USA. Electronic address: rgrosswald@celtaxsys.com.<br /><searchLink fieldCode="AU" term="%22Rowe+SM%22">Rowe SM</searchLink>; Departments of Medicine, Pediatrics, Cell Developmental, and Integrative Biology, University of Alabama at Birmingham, Birmingham, AL, USA; Cystic Fibrosis Research Center, University of Alabama at Birmingham, Birmingham, AL, USA. Electronic address: smrowe@uab.edu. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101242342%22">Contemporary clinical trials</searchLink> [Contemp Clin Trials] 2018 Sep; Vol. 72, pp. 86-94. <i>Date of Electronic Publication: </i>2018 Jul 26. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial Protocol; Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101242342 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1559-2030 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215517144%22">15517144 </searchLink><i>NLM ISO Abbreviation: </i>Contemp Clin Trials <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=30056216 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.cct.2018.07.014 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 86 Titles: – TitleFull: EMPIRE-CF: A phase II randomized placebo-controlled trial of once-daily, oral acebilustat in adult patients with cystic fibrosis - Study design and patient demographics. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Elborn JS – PersonEntity: Name: NameFull: Ahuja S – PersonEntity: Name: NameFull: Springman E – PersonEntity: Name: NameFull: Mershon J – PersonEntity: Name: NameFull: Grosswald R – PersonEntity: Name: NameFull: Rowe SM IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 09 Text: 2018 Sep Type: published Y: 2018 Identifiers: – Type: issn-electronic Value: 1559-2030 Numbering: – Type: volume Value: 72 Titles: – TitleFull: Contemporary clinical trials Type: main |
| ResultId | 1 |
